Header Logo

Connection

MICHAEL JAMES OVERMAN to Glycine

Back to Details
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Glycine.
MICHAEL JAMES OVERMAN
Connection Strength
0.147
Glycine
  1. Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Sci Rep. 2020 02 20; 10(1):3080.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.